Table 3 Replication of the CRNN-snus association in the independent NSPHS cohort.
VIP (n = 133) | Replication NSPHS (n = 501) | |||||
|---|---|---|---|---|---|---|
nbaseline/nrepeat | Beta (SE)a | P | n | Beta (SE)b | P | |
Snus usage | ||||||
Non-user | 91/89 | ref | 420 | ref | ||
Current user | 29/32 | 1.22 (0.18) | 8.5*10−10 | 81 | 1.25 (0.12) | <2*10−16 |
Ex-user | 13/11 | 0.14 (0.29) | — | — | ||
R m 2 = 23% | R m 2 = 18% | |||||
Snus dose | ||||||
Per 1 pack/week | — | — | 0.22 (0.03) | 36*10−15 | ||
— | R2 = 12% | |||||